An exploratory study of perceptions and utilization of genetic information in the intended parent experience of oocyte donor selection.

Carolyn Kalscheur¹, Iman Kashmola-Perez², Laura Rust³, Patricia McCarthy Veach⁴, Krista Redlinger-Grosse⁵

¹Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA. kalscheur.carolyn@mayo.edu.

²Variantyx, Inc., Framingham, MA, USA.

³Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.

⁴University of Minnesota, Minneapolis, MN, USA.

⁵Institute of Human Genetics, University of Minnesota, Department of Genetics, Cell Biology, and Development, Minneapolis, MN, USA.

PubMed PMC DOI PDF

Abstract

PURPOSE: Utilization of oocyte donation has become an increasingly common practice in assisted reproductive technology (ART). Since the introduction of larger carrier screening (CS) panels and extended family medical histories (EFMH), studies have not examined how this information factors into the oocyte donor selection process. This exploratory, qualitative study provides further insight into wha…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.